Abstract
The most common worldwide mutation for cystic fibrosis (CF) is deletion F508 (dF508). Patients homozygous for this mutation have a significantly lower median survival compared to patients carrying other mutations. In the era of newborn screening the diagnosis of patients is relatively easy and fast, while in countries without screening we rely on the clinical presentation.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
